quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 19, 2026

Stock market today: Dow, S&P 500, Nasdaq recover from steep losses as oil's surge eases

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq recover from steep losses as oil's surge eases US stocks cut losses on Thursday as oil prices trimmed gains in afternoon trading on hopes of a deescalation of the conflict in the Middle East…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Israel would help the US open the Strait of Hormuz and the war would end faster than people think

    60% confidence

  • $200 billion for the war in Iran is a small price to pay

    60% confidence

  • The Fed's next policy move will likely be a rate hike in the first half of 2027

    60% confidence

  • Inflation had now been over target for five years

    60% confidence

  • Zero employment growth equilibrium is a balance, but not a comfortable balance

    60% confidence

  • The oil shock could put downward pressure on growth

    60% confidence

  • The macroeconomic environment will continue to be challenging with prices at the pump, sticky inflation, and sluggish job market

    60% confidence

  • Rotation is the lifeblood of a bull market

    60% confidence

Data points we hold from this source

Dow Jones Industrial Average · index close46021.43 points
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Stock market today: Dow, S&P 500, Nasdaq recover from steep losses as oil's surge eases — Source | Via News | pt.VIA.NEWS